MDY's chief exec steps down to save costs
This article was originally published in Clinica
MDY Healthcare, an investor in healthcare companies, has denied that the departure of the company's chief executive Charles Spicer could signal trouble within the organisation. London-based MDY announced on February 20 that following a review of the firm's operations, it concluded that a chief executive was "no longer required" and was eliminating the position as part of a wider-scale cost-cutting programme.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.